Trending...
- Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
- Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
- Peter J. D'Arruda Founder of Capital Financial Joins Tom Hegna on the Podcast "Financial Freedom with Tom Hegna"
INNOVATION PARK, N.C. ~ IQVIA Holdings Inc. (NYSE:IQV) announced today that its wholly-owned subsidiary, IQVIA Inc., has allocated a new term B loan due 2031 of approximately $1,500 million. This loan was upsized due to lender demand.
The proceeds from the new term loan B and the offering of $1,250 million in aggregate principal amount of senior secured notes due 2029 will be used to repay outstanding Euro-denominated and U.S.-denominated term B loans under the Borrower's senior secured credit facilities, as well as to pay fees and expenses related to the Borrower's Notes offering and the Borrower's credit agreement amendment in respect of the New Term Loan B.
In connection with the allocation of the New Term Loan B, IQVIA entered into a cross-currency swap agreement which will effectively convert the New Term Loan B into a euro-denominated borrowing at prevailing euro interest rates to hedge exposure to USD-denominated indebtedness created by the New Term Loan B. The effective net borrowing rate to IQVIA will be 4.9015%, inclusive of the yield on the New Term Loan B and the beneficial impact of the cross-currency swap.
More on ncarol.com
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to life sciences industry. It creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 87,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is also a global leader in protecting individual patient privacy by using a wide variety of privacy-enhancing technologies and safeguards while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with precise treatment paths for better outcomes.
The company's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances in an effort to advance their path toward cures.
The proceeds from the new term loan B and the offering of $1,250 million in aggregate principal amount of senior secured notes due 2029 will be used to repay outstanding Euro-denominated and U.S.-denominated term B loans under the Borrower's senior secured credit facilities, as well as to pay fees and expenses related to the Borrower's Notes offering and the Borrower's credit agreement amendment in respect of the New Term Loan B.
In connection with the allocation of the New Term Loan B, IQVIA entered into a cross-currency swap agreement which will effectively convert the New Term Loan B into a euro-denominated borrowing at prevailing euro interest rates to hedge exposure to USD-denominated indebtedness created by the New Term Loan B. The effective net borrowing rate to IQVIA will be 4.9015%, inclusive of the yield on the New Term Loan B and the beneficial impact of the cross-currency swap.
More on ncarol.com
- UK Financial Ltd Sets Official 30-Day Conversion Deadline for Three Exchange Listed Tokens Ahead of Regulated Upgrade
- New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
- Kentucky Judges Ignore Evidence, Prolong Father's Ordeal in Baseless Case
- Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
- Peter J. D'Arruda Founder of Capital Financial Joins Tom Hegna on the Podcast "Financial Freedom with Tom Hegna"
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to life sciences industry. It creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 87,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is also a global leader in protecting individual patient privacy by using a wide variety of privacy-enhancing technologies and safeguards while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with precise treatment paths for better outcomes.
The company's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances in an effort to advance their path toward cures.
Filed Under: Business
0 Comments
Latest on ncarol.com
- LTL Claims Ratio Index – Update 3Q25
- Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
- Billion Strong Foundation Upgrades 3X Skills + Career Finder and New AI Impact Engine
- Holiday Decorations Most Likely to Cause Injuries
- UK Financial Ltd Confirms Official Corporate Structure of the Maya Preferred Project and Its Dual-Class Token System
- CCHR Florida Joins Global Call to Ban Electroshock Treatment, Citing New Evidence of Widespread Patient Harm
- BoxingRx Announces Full Gym Renovation Ahead of New Ownership's One-Year Anniversary
- UK Financial Ltd Announces It's Official Corporate Headquarters In The United Kingdom
- Greensboro's Leading Custom Sign Company Expands Services to Help Local Businesses Strengthen Their Brand Presence
- Rigani Press Announces Breakthrough Book for Health IT and Medical Leaders to Forge the Road to Responsible AI
- FreeTo.Chat - The bold, Anonymous Confession Platform, ushers in a new era of tension relief
- Cherokee Historical Association Hires Two New Staff Members to Lead New Programming Initiatives
- Hyatt House Fresno Celebrates Grand Opening, Introducing the First Hyatt House in Fresno, California
- "I Make Music Not Excuses" Journal by Anthony Clint Jr. Becomes International Amazon Best Seller, Empowering Music Creators Worldwide
- DanReDev, Kaufman Development & Oldivai Announce Major 2026 Projects Nationwide
- Trusted 24 Hour Mobile Locksmith In Raleigh NC
- More People Than Ever Want a Political Therapist: The Liberatory Wellness Network Is Building a New Standard of Care
- Accelerating Precious Metals Expansion and Digital Asset Innovation Ahead of 2026: Asia Broadband Inc. (Stock Symbol: AABB)
- Naturism Resurgence (NRE) Announces the World's First Standardised Stigma Measure (SSM) for Naturism
- London Art Exchange Emerges as a Leading Force in UK Contemporary Art, Elevating Three Artists to Secondary-Market Success